MCKESSON CORP
For the period ended Mar 31, 2025. Filed May 9, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed May 9, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Financial Note 19 Related Party Balances and Transactions
- Related Party Balances and Transactions
In fiscal 2025, the U.S pharmaceutical sales to one of the Company’s equity method investees totaled $1.1 billion. Trade receivables related to transactions from this investee were $313 million as of March 31, 2025. In fiscal 2024, the Company’s investment in this entity was not accounted for under the equity method and, as a result, was not classified as a related party.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.